Latest Conference Articles

Evaluating efficacy, safety of intracameral dexamethasone 9% vs topical regimen for cataract surgery

Evaluating efficacy, safety of intracameral dexamethasone 9% vs topical regimen for cataract surgery

September 26th 2021

ASCRS

Robert Weinstock, MD, discusses the efficacy and safety of intracameral dexamethasone suspension 9% compared to standard of care topical regimen for eyes receiving cataract surgery.

Evaluating dexamethasone intraocular suspension 9% post-cataract surgery

Evaluating dexamethasone intraocular suspension 9% post-cataract surgery

September 23rd 2021

ASCRS

Cathleen McCabe, MD, shares an overview of results from a retrospective study highlighting the effectiveness of dexamethasone intraocular suspension 9% following cataract surgery.

ViaLase CEO talks innovations in glaucoma treatment

ViaLase CEO talks innovations in glaucoma treatment

September 21st 2021

ASCRS

Tibor Juhasz, CEO of ViaLase, Inc, discusses the company's development of a novel, noninvasive high-resolution OCT image-guided femtosecond laser technology for the treatment of open-angle glaucoma.

Collagen crosslinking provides corneal stability in young patients

Collagen crosslinking provides corneal stability in young patients

September 13th 2021

ASCRS

CXL is safe, effective to perform on younger population, study results show.

Study targets intravitreal injections for AMD, PCR risks

Study targets intravitreal injections for AMD, PCR risks

September 13th 2021

EURETINA

Marta Belmonte-Grau, MD discusses the potential risk for posterior capsular rupture during cataract surgery.

Providing virtual care for diabetic eye disease patients

Providing virtual care for diabetic eye disease patients

September 12th 2021

EURETINA

Tunde Peto, MD, offers advice on how to create the best virtual environment for patients diagnosed with diabetic eye disease.

Retinal detachments: managing retinal folds, role of anterior vitreous

Retinal detachments: managing retinal folds, role of anterior vitreous

September 11th 2021

EURETINA

Grazia Pertile, MD, discusses the highlights of her presentations on the management of retinal folds after retinal detachment and the role of the anterior vitreous as a cause of recurrent retinal detachment.

Investigating suitable naïve versus pre-treated DME patients

Investigating suitable naïve versus pre-treated DME patients

September 11th 2021

EURETINA

Javier Zarranz-Ventura MD, PhD, FEBO, discusses the key highlights from his presentation on a clinical investigation of suitable naïve versus pre-treated DME patients, and what it means for future research.

AI: Capturing more information from OCT in wet AMD

AI: Capturing more information from OCT in wet AMD

September 10th 2021

EURETINA

Anat Loewenstein, MD, MHA, discusses how artificial intelligence can optimize optical coherence tomography.

Challenges of treating peripheral hemorrhagic polypoidal choroidal vasculopathy

Challenges of treating peripheral hemorrhagic polypoidal choroidal vasculopathy

September 10th 2021

EURETINA

A case study details the care of a patient who had already lost vision in one eye from a similar issue.